Amgen publishing on 'emerging modality', RNAi:Plasma and liver protein binding of GalNAc conjugated | ARWR Message Board Posts

Arrowhead Pharmaceuticals, Inc.

  ARWR website

  • To open or close the box of links at the top of your board, click the "hide/show" button to the right of your page, as shown here:


    To view a vertical list of all your board links on a separate page, click the "View Full List" link in parentheses.

    In the meantime, we will see what we can do to bring more attention to the "hide/show" button, such as making it bigger and/or adding color to it.

    Please continue sending constructive feedback via PM to Admin or email admin@investorvillage.com. We appreciate hearing from you!

ARWR   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  10008 of 10159  at  6/18/2019 10:05:54 AM  by

biochemyst


 In response to msg 10007 by  Aspector
view thread

Re: Amgen publishing on 'emerging modality', RNAi:Plasma and liver protein binding of GalNAc conjugated siRNA

 I see zero chance for PCSK9 mabs once MDCO's RNAi-based inhibitor is approved. Mabs are massively expensive, require IV administration, and have poor PD (redone every couple weeks).  
 
It may be the case that lowering triglycerides is the 1-2 punch that results in such a massive lowering if cardiovascular disease we start calling these drugs the "heart-attack vaccines"
 
Of course Amgen could buy just that drug, but it's clear they love the whole sand box.  They seem to be spending vast time and resources investigating RNAi, so why not bolt it on when you're sure it's ready? 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 7     Views: 305
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
10010 Re: Amgen publishing on 'emerging modality', RNAi:Plasma and liver protein binding of GalNAc conjugated siRNA jetmanbash 0 6/18/2019 8:51:42 PM






Financial Market Data provided by
.


Loading...